Association of the Khorana Score with development of venous thromboembolism in ovarian cancer.

被引：2
|
作者：
Marcus, Ellen
Kuo, Dennis Yi-Shin
Nevadunsky, Nicole Suzanne
Gressel, Gregory M.
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Dept Obstet Gynecol & Womens Hlth, 111 E 210th St, Bronx, NY 10467 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.5555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5555
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors
    Stancu Alma
    Debourdeau Eloi
    Vazquez Léa
    Coussirou Julie
    Matagne Valérie
    Grassi Pierre
    Werner Hilgers
    Girard Philippe
    Zammit Christine
    Debourdeau Philippe
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 287 - 294
  • [42] Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors
    Alma, Stancu
    Eloi, Debourdeau
    Lea, Vazquez
    Julie, Coussirou
    Valerie, Matagne
    Pierre, Grassi
    Hilgers, Werner
    Philippe, Girard
    Christine, Zammit
    Philippe, Debourdeau
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (02) : 287 - 294
  • [43] Venous thromboembolism in ovarian cancer
    Rodriguez, Anne O.
    Wun, Ted
    Chew, Helen
    Zhou, Hong
    Harvey, Danielle
    White, Richard H.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 784 - 790
  • [44] Risk assessment of venous thromboembolism in lung cancer - Utility of Khorana model
    Gaspar, Carina
    Ferreira, Dalila
    Simoes, Susana
    Alves, Paula
    Costa, Agostinho
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [45] The Rate of Venous Thromboembolism in Cancer Patients Varies By Khorana Risk Category
    Khorana, Alok A.
    Kuderer, Nicole M.
    McCrae, Keith R.
    Milentijevic, Dejan
    Germain, Guillaume
    Laliberte, Francois
    Nguyen Le
    Lefebvre, Patrick
    Lyman, Gary H.
    Streiff, Michael B.
    BLOOD, 2018, 132
  • [46] Validation of the Khorana Score to Assess Venous Thrombolembolism and Its Association with Mortality
    Ahmed, Gulrayz
    Hall, Kathryn Tayo
    Weissmann, Lisa Beth
    BLOOD, 2019, 134
  • [47] The incidence and time course of venous thromboembolism among California women with ovarian cancer.
    Wun, T
    Chew, HK
    Zhou, H
    Harvey, D
    White, RH
    BLOOD, 2003, 102 (11) : 554A - 555A
  • [48] Validation and comparison of the Protecht, Conko, and Khorana score for prediction of venous thromboembolism in ambulatory cancer patients: a retrospective cohort study
    Guman, N. A.
    Mulder, F. I.
    van Es, N.
    Beerepoot, L. V.
    van Laarhoven, H.
    Lolkema, M.
    Buller, H. R.
    THROMBOSIS RESEARCH, 2021, 200 : S65 - S66
  • [49] Performance of Khorana Score to Predict One-Year Risk of Venous Thromboembolism in over Two Million Patients with Cancer
    Arafah, Yasmin
    Al-Juhaishi, Taha
    Abu Zeinah, Ghaith
    Nayak, Lalitha V.
    Al-Kindi, Sadeer
    BLOOD, 2020, 136
  • [50] Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients
    Hiraide, Makoto
    Shiga, Taro
    Minowa, Yuichi
    Nakano, Yasuhiro
    Yoshioka, Hidenori
    Suzuki, Kenichi
    Yasuda, Chikao
    Takahashi, Harumi
    Hama, Toshihiro
    JOURNAL OF CARDIOLOGY, 2020, 75 (01) : 110 - 114
12345